西部牧业 reported revenue of ¥0.48B for the period ended 2026-06-30, +22.4% year on year. Net income was ¥0.04B, a 8.6% net margin on a 12.2% gross margin. The largest revenue line is 乳制品 at 89% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.48B | +22.4% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.04B | — |
| Gross margin | 12.2% | Net margin 8.6% |
| Revenue Q/Q | +1.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 乳制品 | ¥0.43B | 88.9% |
| 其他业务 | ¥0.05B | 11.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.43B | 87.8% |
| R&D | ¥0.00B | 0.2% |
| SG&A | ¥0.06B | 11.9% |
| Tax & other | ¥0.00B | 0.0% |
| Item | Amount |
|---|---|
| Total assets | ¥1.08B |
| Total liabilities | ¥0.55B |
| Shareholders' equity | ¥0.54B |
| Equity / assets | 49.6% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 144% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
建新股份 ・ 新开源 ・ 华仁药业 ・ 向日葵 ・ 万讯自控 ・ 顺网科技 ・ 长盈精密 ・ 东方日升 ・ 瑞普生物 ・ 经纬辉开 ・ 阳谷华泰 ・ ST亚光
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies